Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5357| Title: | Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis | Authors: | Legg, Amy Roberts, Matthew A Davies, Jane Cass, Alan Meagher, Niamh Sud, Archana Daitch, Vered Dishon Benattar, Yael Yahav, Dafna Paul, Mical Xinxin, Chen Ping, Yeo He Lye, David Lee, Russel Robinson, J Owen Foo, Hong Tramontana, Adrian R Bak, Narin Grenfell, Adelaide Rogers, Benjamin Li, Ying Joshi, Neela O'Sullivan, Matthew McKew, Genevieve Ghosh, Niladri Schneider, Kellie Holmes, Natasha E Dotel, Ravindra Chia, Timothy Archuleta, Sophia Smith, Simon Warner, Morgyn S Titin, Christina Kalimuddin, Shirin Roberts, Jason A Tong, Steven Y C Davis, Joshua S |
Issue Date: | 2023 | Publisher: | Infectious Diseases Society of America | Source: | Legg A, Roberts MA, Davies J, Cass A, Meagher N, Sud A, Daitch V, Dishon Benattar Y, Yahav D, Paul M, Xinxin C, Ping YH, Lye D, Lee R, Robinson JO, Foo H, Tramontana AR, Bak N, Grenfell A, Rogers B, Li Y, Joshi N, O'Sullivan M, McKew G, Ghosh N, Schneider K, Holmes NE, Dotel R, Chia T, Archuleta S, Smith S, Warner MS, Titin C, Kalimuddin S, Roberts JA, Tong SYC, Davis JS; Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Study Group. Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis. Open Forum Infect Dis. 2023 Jul 3;10(7):ofad337. doi: 10.1093/ofid/ofad337. PMID: 37496601; PMCID: PMC10368200. | Journal: | Open forum infectious diseases | Abstract: | The Combination Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus (CAMERA2) trial ceased recruitment in July 2018, noting that a higher proportion of patients in the intervention arm (combination therapy) developed acute kidney injury (AKI) compared to the standard therapy (monotherapy) arm. We analyzed the long-term outcomes of participants in CAMERA2 to understand the impact of combination antibiotic therapy and AKI. | Description: | Cairns & Hinterland Hospital and Health Service (CHHHS) affiliated author: Simon Smith | DOI: | 10.1093/ofid/ofad337 | Keywords: | acute kidney injury;nephrotoxicity;Staphylococcus aureus bacteremia | Type: | Article |
| Appears in Sites: | Cairns & Hinterland HHS Publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Longer-term mortality and kidney outcomes of participants in the CAMERA2 trial.pdf | 676.69 kB | Adobe PDF |  View/Open |
Page view(s)
72
checked on Dec 23, 2024
Download(s)
28
checked on Dec 23, 2024
Google ScholarTM
Check
Altmetric
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.